U.S. - Vaccines For Veterinary Medicine - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVeterinary Medicine Vaccines Prices in the United States
U.S. Veterinary Medicine Vaccines Export Price in December 2021
In December 2021, the veterinary medicine vaccines price stood at $78.8 per kg (FOB, US), approximately mirroring the previous month. Over the period under review, the export price showed a relatively flat trend pattern. The growth pace was the most rapid in October 2021 when the average export price increased by 16% month-to-month. As a result, the export price attained the peak level of $83,024 per ton. From November 2021 to December 2021, the the average export prices remained at a somewhat lower figure.
There were significant differences in the average prices for the major foreign markets. In December 2021, the country with the highest price was Thailand ($99.2 per kg), while the average price for exports to Taiwan (Chinese) ($34.8 per kg) was amongst the lowest.
From January 2021 to December 2021, the most notable rate of growth in terms of prices was recorded for supplies to Germany (+10.0%), while the prices for the other major destinations experienced more modest paces of growth.
U.S. Veterinary Medicine Vaccines Exports
Veterinary medicine vaccines exports from the United States declined to 514 tons in December 2021, waning by -9.5% compared with the previous month. Overall, exports, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in May 2021 when exports increased by 33% m-o-m. As a result, the exports reached the peak of 797 tons. From June 2021 to December 2021, the growth of the exports failed to regain momentum.
In value terms, veterinary medicine vaccines exports contracted to $41M (IndexBox estimates) in December 2021. Over the period under review, exports, however, saw a relatively flat trend pattern. The growth pace was the most rapid in May 2021 with an increase of 28% m-o-m. As a result, the exports reached the peak of $60M. From June 2021 to December 2021, the growth of the exports failed to regain momentum.
U.S. Veterinary Medicine Vaccines Exports by Country
Brazil (77 tons), Canada (74 tons) and Mexico (64 tons) were the main destinations of veterinary medicine vaccines exports from the United States, with a combined 42% share of total exports. These countries were followed by China, South Korea, Belgium, Vietnam, the Philippines, Spain, Thailand, Japan, Germany and Taiwan (Chinese), which together accounted for a further 36%.
From January 2021 to December 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Germany (with a CAGR of +8.5%), while the other leaders experienced more modest paces of growth.
In value terms, Canada ($6.8M), Mexico ($5.8M) and Brazil ($4.9M) were the largest markets for veterinary medicine vaccines exported from the United States worldwide, together comprising 43% of total exports. These countries were followed by China, Thailand, the Philippines, Vietnam, South Korea, Belgium, Germany, Spain, Japan and Taiwan (Chinese), which together accounted for a further 30%.
Germany, with a CAGR of +19.3%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202160 - Vaccines for veterinary medicine
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
360
This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S..
470
This report provides an in-depth analysis of the antisera market in the U.S..
595
This report provides an in-depth analysis of the biological product market in the U.S..
522
This report provides an in-depth analysis of the vaccine market in the U.S..
421
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
677
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
2037
This report provides an in-depth analysis of the global antisera market.
463
This report provides an in-depth analysis of the global biological product market.
2671
This report provides an in-depth analysis of the global vaccine market.
529
This report provides an in-depth analysis of the global market for human and animal blood.
146
Haleon invests $54M in its U.S. R&D centre to drive innovation in consumer healthcare, enhancing its product pipeline and maintaining competitive edge.
624
For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by...
146
U.S. experts predict a smaller winter COVID wave, posing challenges for Pfizer amid declining revenues, emphasizing the need to diversify non-COVID products.
272
Explore Moderna's ongoing phase three norovirus vaccine trial targeting urgent prevention needs amid rising outbreaks in the U.S.
239
Moderna has secured $590 million to enhance pandemic influenza vaccine development, focusing on mRNA technology and expanding human trials.
125
Moderna's shares increased by over 10% due to progress in H5N1 vaccine development following a human fatality in the U.S.
108
In the period of 2018 to 2024, the growth of exports for Human And Animal Blood failed to regain momentum. The value of exports declined to $3.5B in 2024.
1385
From February 2023 to December 2023, the exports of Human And Animal Blood saw a significant decline, dropping to $71M in value.
112
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
246
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
